Bevacizumab Recall: RC Outsourcing intravitreal syringes
FDA recalls RC Outsourcing Bevacizumab 0.25 mL intravitreal syringes due to lack of assurance of sterility. Approximately 2,669 syringes distributed nationwide in the US for hospital/office use (Rx Only) that require refrigeration are affected. Affected lots include 20250708-768A26, 20250715-944DF2, 20250722-55C603, and 20250722-5DC113 with BUDs Oct 06, Oct 13, and Oct 20, 2025.
| Brand | RC Outsourcing, LLC |
|---|---|
| Product | Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436. |
| Reason | Lack of assurance of sterility. |
| Severity | moderate |
| Units affected | 2669 |
| Distribution | Nationwide in the US |
| Agency | FDA |
WHAT YOU SHOULD DO
- Do not use the recalled syringes.
- Quarantine and return or dispose of affected lots: 20250708-768A26; 20250715-944DF2; 20250722-55C603; 20250722-5DC113 (BUDs Oct 06, 13, or 20, 2025).
- Contact the hospital or clinic where you obtained the product for disposal or replacement instructions.
- If you have questions, contact your healthcare provider or the FDA.
How to identify the recalled item
| Lot / date codes | Lot # 20250708-768A26, BUD: Oct 06, 2025 20250715-944DF2 BUD: Oct 13, 2025 20250722-55C603 BUD: Oct 20, 2025 20250722-5DC113 BUD: Oct 20, 2025 |
|---|---|
| Lot / date codes | Lot # 20250708-768A26, BUD: Oct 06, 2025 20250715-944DF2 BUD: Oct 13, 2025 20250722-55C603 BUD: Oct 20, 2025 20250722-5DC113 BUD: Oct 20, 2025 |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
Other bevacizumab recalls
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.